PropertyValue
?:definition
  • Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., seminal plasma, serum) to determine circulating antibodies against the cells of the walls of body cavities (i.e., parietal cell antibodies [PCAs]). High levels of PCA, especially in diabetes type I patients, are associated with autoimmune gastric diseases, particularly to chronic atrophic gastritis and pernicious anemia.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C3691845_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C3691845_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all